Form D · Pharmaceuticals
Vitae Pharmaceuticals, Inc
Fort Washington, PA · CIK 0001157602
Offering snapshot reported Jun 10, 2009 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 5, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2009 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Sep 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 11, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-56589
Source: Form D, filed Jun 10, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Barrett | Director |
| Tina Fiumenero | Executive |
| Richard Gregg | Executive |
| Robert Gunderson | Director |
| Jeffrey Hatfield | Director, Executive |
| Donald Hayden | Director |
| Charles Newhall | Director |
| Bryan Roberts | Director |
| James Tananbaum | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
502 West Office Center Dr
Fort Washington, PA, 19034
Fort Washington, PA, 19034